U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07737990) titled 'Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression' on July 27.
Brief Summary: Psilocybin-assisted psychotherapy requires a lot of resources, with more psychotherapy being provided to integrate the meanings and insights derived from the psilocybin dosing sessions. If group integration therapy is beneficial, then it has the potential to reduce resources required per patient for psilocybin-assisted psychotherapy, thereby increasing the cost-effectiveness of the treatment. However, no research has been done to understand if and how group therapy can support psychedelic integration for people with moo...